Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

By Braud A.C.   Asselain B.   Scholl S.   De La Rochefordiere   Palangie T.   Dieras V.   Pierga J.Y.   Dorval T.   Jouve M.   Beuzeboc P.   Pouillart P.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Efficacy and feasibility of neoadjuvant chemotherapy with FEC 100 followed by weekly paclitaxel for operable breast cancer

By                

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 612-616

Spandidos Publications

Access to resources Recommend Favorite

Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

By Romero A.   Garca-Senz J. A.   Fuentes-Ferrer M.   Lpez Garcia-Asenjo J. A.   Furi V.   Romn J. M.   Moreno A.   de la Hoya M.   Daz-Rubio E.   Martn M.   Calds T.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 655-661

Oxford University Press

Access to resources Recommend Favorite

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

By Wang Jiayu  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 531-537

Springer Publishing Company

Access to resources Recommend Favorite